Diabetes drug repurposed to fight rare, painful kidney stones
NCT ID NCT04818034
Summary
This small study tested whether a diabetes medication called dapagliflozin could help prevent cystine kidney stones. Researchers gave the drug to 10 adults with cystinuria, a genetic condition that causes painful, recurring stones. They wanted to see if the glucose the drug adds to urine could stop cystine crystals from forming and clumping into stones.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTINURIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of California, San Francisco
San Francisco, California, 94143, United States
Conditions
Explore the condition pages connected to this study.